Literature DB >> 7030473

Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients.

G Frizzera, D W Hanto, K J Gajl-Peczalska, J Rosai, R W McKenna, R K Sibley, K P Holahan, L L Lindquist.   

Abstract

The lymphoproliferative processes that developed in five renal transplant recipients were studied in an attempt to characterize and classify them morphologically. Nine surgical specimens, hematological material on all patients, and autopsy specimens from three patients were available. Studies performed included: conventional histopathology; evaluation of cell markers (immunoglobulins and sheep erythrocyte, complement, and Fc receptors) and cytoplasmic immunoglobulins (peroxidase-antiperoxidase technique); ultrastructural examination; and karyotype analysis. The lymphoid lesions in our patients shared marked cytological polymorphism (small and large cells, of both follicular center and "medullary" type) and polyclonal B-cell features, which indicated a common reactive nonneoplastic origin. However, other features, such as morphological atypia of the immunoblasts, extensive necrosis, chromosomal aberrations, and an incipient monoclonal component suggested the development of lymphoma in some of these lesions. In contradistinction, the abundance of typical immunoblasts was a feature that seemed to correlate with the clinical activity of the disease rather than with the biological malignancy. The multiplicity of B-cell types and the presence of a follicular center cell component with diffuse distribution, as well as the extensive necrosis in the malignant forms, seem to differentiate morphologically the lymphoproliferative processes arising in transplant recipients from both the hyperplasias and the lymphomas developing in immunologically normal hosts. For the former, we propose the terms of "polymorphic diffuse B-cell hyperplasias" and "polymorphic B-cell lymphomas."

Entities:  

Mesh:

Year:  1981        PMID: 7030473

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  56 in total

1.  Immature and transitional B cells are latency reservoirs for a gammaherpesvirus.

Authors:  Carrie B Coleman; Michael S Nealy; Scott A Tibbetts
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Epstein-Barr and human immunodeficiency viruses in acquired immunodeficiency syndrome-related primary central nervous system lymphoma.

Authors:  S Morgello
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

3.  Histiocytic Lymphoma in Renal Transplant Patients Receiving Cyclosporine.

Authors:  J T Rosenthal; S Iwatsuki; T E Starzl; R J Taylor; T R Hakala
Journal:  Transplant Proc       Date:  1983-12       Impact factor: 1.066

4.  Virus-associated haemophagocytic syndrome with Epstein-Barr virus infection.

Authors:  K Ohshima; M Kikuchi; F Eguchi; S Kobari; H Tasaka
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

Review 5.  Lymphoproliferative disease in organ transplant recipients.

Authors:  M A Nalesnik
Journal:  Springer Semin Immunopathol       Date:  1991

6.  Lymphoproliferative disorders arising under immunosuppression with FK 506: initial observations in a large transplant population.

Authors:  M A Nalesnik; A J Demetris; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

7.  Development of lymphoma from the donor of haploidentical stem cell transplantation: A case report.

Authors:  Linna Xie; Fang Zhou
Journal:  Mol Clin Oncol       Date:  2017-09-19

8.  Molecular genetic analysis of lymphoid tumors arising after organ transplantation.

Authors:  J Locker; M Nalesnik
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

Review 9.  Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders.

Authors:  M A Nalesnik; T E Starzl
Journal:  Transplant Sci       Date:  1994-09

10.  AIDS-related lymphoma. Histopathology, immunophenotype, and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization.

Authors:  S J Hamilton-Dutoit; G Pallesen; M B Franzmann; J Karkov; F Black; P Skinhøj; C Pedersen
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.